Last reviewed · How we verify
GRT6019
At a glance
| Generic name | GRT6019 |
|---|---|
| Also known as | Study drug |
| Sponsor | Grünenthal GmbH |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Study to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]GRT6019 (PHASE1)
- A Trial to Investigate Safety and Pharmacokinetics of GRT6019, Including Food Effect, in Healthy Male Participants (PHASE1)
- A Trial to Investigate the Safety and Pharmacokinetics of GRT6019 in Healthy Male Participants (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- GRT6019 CI brief — competitive landscape report
- GRT6019 updates RSS · CI watch RSS
- Grünenthal GmbH portfolio CI